콘텐츠로 건너뛰기
Merck
모든 사진(2)

Key Documents

911925

Sigma-Aldrich

NanoFabTx microfluidic chip

for 1-5 μm particles

동의어(들):

Microfluidic kit, Microparticle, NanoFabTx, Nanoformulation

로그인조직 및 계약 가격 보기


About This Item

UNSPSC 코드:
41116105
UNSPSC 코드:
41121800
NACRES:
NC.25

설명

Microfludic hardware kit component for synthesizing 1-5 μm microparticles

Kit components :

  • Microfluidic chip x 1

Quality Level

응용 분야

advanced drug delivery

유사한 제품을 찾으십니까? 방문 제품 비교 안내

일반 설명

NanoFabTx microfluidic chip, for 1-5 μm particles is a component of our NanoFabTx microfluidic - micro, device kit for synthesis of 1-5 µm particles (911860). The kit additionally includes a protocol, supporting manifold, tubing, and additional accessories for microfluidic-based synthesis.

애플리케이션

NanoFabTx microfluidic chips precisely control and manipulate fluids on the microscale. Their well-controlled geometries enable facile syntheses of monodisperse polymeric microparticles. NanoFabTx microfluidic chip, for 1-5 μm particles can be used as a replacement for the component in our NanoFabTx microfluidic - micro, device kit for synthesis of 1-5 μm particles (911860).

법적 정보

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

시험 성적서(COA)

제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.